LUNG — Pulmonx Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1127537 ·
Last close
$1.91
Market Cap
$82.03M
52W High
$2.89
52W Low
$1.13
ADV30
352,397
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 20,586,000 | 16,044,000 | -12,956,000 | -13,654,000 | 119,966,000 | 61,572,000 | 74,205,000 |
| Dec 2025 | 22,598,000 | 17,541,000 | -9,903,000 | -10,425,000 | 129,291,000 | 69,751,000 | 75,175,000 |
| Sep 2025 | 21,502,000 | 16,052,000 | -14,393,000 | -13,957,000 | 138,281,000 | 76,549,000 | 78,248,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,557,000
Investing CF
$8,688,000
Financing CF
$1,749,000
CapEx
$-112,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.16
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-545,292,000
Inventory
$16,390,000
Receivables
$12,727,000
ST Investments
$0
EBIT TTM
$-43,751,000
Pretax Income TTM
$-47,520,000
Interest Exp TTM
$3,769,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$87,442,000
EBITDA
$-45,490,000
Free Cash Flow
$-11,744,750
Enterprise Value
$79,822,296
Total Cash
$55,843,000
Total Debt
$56,211,000
Shares Out
42,948,269
Trailing EPS
$-1.15
Book Value
$0.91
ROE
-88.9%
ROA
-22.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 90,497,000 | -53,663,000 | -54,003,000 | 129,291,000 | 75,175,000 | 54,116,000 | -32,376,000 |
| Dec 2024 | 83,789,000 | -57,704,000 | -56,394,000 | 162,850,000 | 77,041,000 | 85,809,000 | -31,537,000 |
| Dec 2023 | 68,675,000 | -61,935,000 | -60,843,000 | 177,781,000 | 59,466,000 | 118,315,000 | -37,610,000 |
| Dec 2022 | 53,662,000 | -58,637,000 | -58,923,000 | 193,676,000 | 39,669,000 | 154,007,000 | -45,083,000 |
TTM Snapshot
Revenues TTM
$74,095,000
NetIncome TTM
$-57,664,000
OpCashFlow TTM
$0
Assets (Latest)
$129,291,000
Forward EPS
$-0.94
Max Pain — expiry 2026-10-16
max pain strike: $2.50 · spot: $1.97 · call oi: 2,097 · put oi: 0
Expected Move to 2026-10-16:
±$0.66
(33.50%) —
implied range
$1.31 –
$2.63
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| STEX | Streamex Corp. | $81.53M | $0.70 | — |
| LNSR | LENSAR, Inc. | $85.02M | $6.92 | — |
| MBOT | Microbot Medical Inc. | $85.97M | $1.28 | — |
| SKIN | SkinHealth Systems Inc. | $86.54M | $0.67 | — |
| GUTS | FRACTYL HEALTH, INC. | $77.36M | $0.49 | — |
News headlines (Yahoo Finance, 1h cache)
Pulmonx Shares Fall Following Recent Gains
2026-09-03 12:28 · Yahoo
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-01 20:05 · Yahoo
Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy?
2026-08-26 13:55 · Yahoo
What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now?
2026-08-14 16:00 · Yahoo
Pulmonx (LUNG) Q2 2026 Earnings Call Transcript
2026-08-08 01:02 · Yahoo
Pulmonx Q2 Earnings Call Highlights
2026-07-29 23:04 · Yahoo
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026
2026-07-15 20:05 · Yahoo
Pulmonx (LUNG) Q1 2026 Earnings Transcript
2026-04-30 16:25 · Yahoo
Pulmonx Corp (LUNG) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
2026-04-30 07:17 · Yahoo
Pulmonx Corporation Q1 2026 Earnings Call Summary
2026-04-30 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.